Retrospective Analysis of 1545 Patients: Neuroimaging in Headache
Abstract
Objective: Neuroradiological imaging is also used to differentiate between primary and secondary headaches. The aim of this study was to evaluate retrospectively the significant abnormal neuroradiological imaging results and rates in the primary headache group. In addition, it was also planned to analysis the results of all headaches with imaging and discuss the imaging in the headache with the literature.
Methods: Medical records of headache patients of the neurology outpatient clinic at the tertiary care center were reviewed. Patients who required brain imaging and did not have any disease that could cause pathology in imaging were included. Neuroradiological images were grouped as brain computed tomography (CT), brain magnetic resonance imaging (MRI) and others. Results were normal, significant abnormal findings and others.
Results: Total 1545 patients were included. Primary headache 992, secondary headache 91, painful cranial neuropathies and other headaches were observed in 462 patients. Significant abnormal radiological findings were found to be 4.3% in primary headache, 14.3% in secondary headache, and 6.6% in painful cranial neuropathy and other headaches. Significant findings in primary headache were Arnold Chiari Malformation, sinus thrombosis, intracranial mass, choroid plexus xanthogranuloma, hydrocephalus, vascular malformation.
Conclusion: In this series, the rate of significant findings in neuroradiological imaging in primary headache is low. Secondary headaches require neuroimaging because of the presence of underlying life-threatening causes, although the rate of abnormal neuroradiological imaging is low. History, examination, and red flags in headache may lead to imaging, but patient and physician concerns may also increase imaging rates.
References
REFERENCES
Vost T, Falxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al. Years lived with disability (YLDs) for 1160 sequale of 289 diseases and injuries 1990-2010: a systematic analysis fort he Global Burden of Disease Study 2010. Lancet 2012;15:2163-96.
McCrory DC, Matchar DB, Rosenberg JH, Silberstein SD. Evidence-based guidelines for migraine headache: overview of program description and methodology. Minneapolis, Minn: American Academy of Neurology; 2000. http://w w w. aan.com /professionals/practice/pdfs/gl0086.pdf. Accessed November 7, 2005.
De Luca GC, Bartleson JD. When and how to investigate the patient with headache. Semin Neurol 2010; 30:131–44.
Feoktistov A, Diamond M. Diagnosing and understanding adult headache. Otolaryngol Clin North Am 2014;47(2):175-85.
Larson EB, Omenn GS, Lewis H. Diagnostic evaluation of headache. Impact of computerized tomography and costeffectiveness. JAMA 1980; 243:359–62.
Demaerel P, Boelaert I, Wilms G, Baert AL. The role of cranial computed tomography in the diagnostic work-up of headache. Headache 1996; 36:347–88.
Dumas MD, Pexman JH, Kreeft JH. Computed tomography. evaluation of patients with chronic headache. Can Med Assoc J 1994; 151:1447–52.
Akpek S, Arac M, Atilla S, Onal B, Yucel C, Isik S. Costeffectiveness of computed tomography in the evaluation of patients with headache. Headache 1995; 35:228–30.
Weingarten S, Kleinman M, Elperin L, Larson EB. The effectiveness of cerebral imaging in the diagnosis of chronic headache. Arch Intern Med 1992; 152:2457–62.
Wang HZ, Simonson TM, Greco WR, Yuh WTC. Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms. Acad Radiol 2001; 8: 405–408.
Tsushima Y, Endo K. MR imaging in the evaluation of chronic or recurrent headache. Radiology 2005;235(2):575-79.
Sempere AP, Porta-Etessam J, Medrano V, Garcia-Morales I, Concepción L, Ramos A, et al. Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia 2005;25(1):30-35.
Jamieson DG, Hargreaves R. The role of neuroimaging in headache. J Neuroimaging 2002;12(1):42-51.
Evans RM. İncidental findings and normal anatomic variants on MRI of the brain in adults for primary headaches. Headache 2017;57(5):780-791.
Nelson S, Taylor LP. Headaches in brain tumor patients: primary or secondary? Headache 2014;54(4):776-85.
A Romano, V Cipriani, A Bozzao. Neuroradiology and headaches. J Headache Pain 2006;7:422–32.
Wilhour D, Nahas SJ. The Neuralgias. Curr Neurol Neurosci Rep 2018;18(10):69.
Silberstein SD and Consortium UH. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 754–62.
Wang R, Liu R, Dong Z, Su H, Ao R, Liu Y, et al. Unnecessary Neuroimaging for Patients With Primary Headaches. Headache 2019;59(1):63-68.
K Ravishankar. WHICH headache to investigate, WHEN, and HOW?. Headache 2016;56:1685-97.
Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, et al. Gantenbein AR, Schoonman GG. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 2019;92(3):134-44.
Young NP, Elrashidi MY, McKie PM, Ebbert JO. Neuroimaging utilization and findings in headache outpatients: Significance of red and yellow flags. Cephalalgia 2018;38(12):1841-48.
Callaghan BC, Kerber KA, Pace RJ, Skolarus L, Cooper W, Burke JF. Headache neuroimaging: Routine testing when guidelines recommend against them. Cephalalgia 2015;35(13):1144-52.
Cote DJ, Laws ER Jr. The Ethics of "Choosing Wisely": The Use of Neuroimaging for Uncomplicated Headache. Neurosurgery 2017;1;80(5):816-819.
